Jul. 9 at 5:08 PM
The market is not just a handful of AI/memory names.
There are many other sectors and stocks acting incredibly well that most investors are missing. The rally has broadened far beyond the obvious AI and memory trade.
Here are some of the key sectors and names to watch:
Biotech/Healthcare
$ERAS
$IBRX
$ABCL
$QURE
$HNGE
The macro landscape is structurally shifting! Smart money is actively broadening the rally, rotating out of overcrowded AI and memory nodes into deeply discounted, hyper-growth Biotech and Healthcare assets.
These listed names represent the ultimate asymmetric frontrunners of this rotation. We are looking at massive institutional accumulation in IBRX following its oncology pipeline acceleration, alongside gene-therapy pioneer QURE which delivered multi-bagger returns on breakthrough FDA regulatory paths. Meanwhile, platforms like ABCL and ERAS are seeing intense volume expansion ahead of crucial data readouts. As the market pivots from pure hardware infrastructure toward growth diversification, biotech is emerging as the premier destination for high-conviction alpha.
Is this biotech surge a tactical, near-term capital pitstop, or the start of a multi-year secular bull run for healthcare? Which high-reward play are you backing for the next leg up: ERAS, IBRX, ABCL, QURE, or HNGE? Let's talk shop below!
